Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
Bionano Genomics, Inc. (BNGO)
Last bionano genomics, inc. earnings: 8/8 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Full Year 2025 Revenue: $28.5 million, down 7% from $30.8 million in 2024. Non-GAAP Gross Margin Q4 2025: 43%, up from 42% in Q4 2024. Non-GAAP Gross Margin Full Year 2025: 47%, up from 35% in 2024. Non-GAAP Operating Expense Q4 2025: $9.7 million, down 9% year-over-year. Non-GAAP Operating Expense Full Year 2025: $36.6 million, down 47% from $68.9 million in 2024. Cash and Equivalents End of 2025: $29.6 million, including $10.3 million subject to restrictions. Flow Cells Sold Q4 2025: 7,554, down 6% year-over-year. Flow Cells Sold Full Year 2025: 30,171, down 0.4% year-over-year. OGM Systems Installed Q4 2025: 9 systems. OGM Systems Installed Full Year 2025: 32 systems, exceeding guidance of 15 to 20. Consumables and Software Revenue Q4 2025: Decreased by 1% to $4.8 million. Consumables and Software Revenue Full Year 2025: Grew 7% from $19 million to $20.4 million. Revenue Guidance for Full Year 2026: $30 million to $33 million, representing 5% to 16% growth
Show less
Read more
Impact Snapshot
Event Time:
BNGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNGO alerts
High impacting Bionano Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
BNGO
News
- Earnings Snapshot: Bionano Genomics beats Q4 top-line but guides Q1, FY25 revenue below estimates [Seeking Alpha]Seeking Alpha
- Bionano Genomics reports Q4 results [Seeking Alpha]Seeking Alpha
- Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026GlobeNewswire
- Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting [Yahoo! Finance]Yahoo! Finance
- Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics MeetingGlobeNewswire
BNGO
Sec Filings
- 3/25/26 - Form S-8
- 3/23/26 - Form 10-K
- 3/23/26 - Form 8-K
- BNGO's page on the SEC website